Hoppenot Herve 4
4 · INCYTE CORP · Filed Jun 30, 2025
Insider Transaction Report
Form 4
INCYTE CORPINCY
Hoppenot Herve
DirectorChief Executive OfficerOther
Transactions
- Award
Performance Shares
2025-06-26+18,050→ 18,050 totalExp: 2028-06-26→ Common Stock (18,050 underlying) - Award
Common Stock
2025-06-26+6,016→ 569,589 total - Award
Employee Stock Option (right to buy)
2025-06-26+18,438→ 18,438 totalExercise: $70.81Exp: 2035-06-25→ Common Stock (18,438 underlying)
Footnotes (4)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Including the June 26, 2025 grant, this includes an aggregate of 187,611 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
- [F3]The June 26, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- [F4]Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ('TSR') over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date.